JNJ-31001074

DRUG6 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen Research & Development, LLC

Conditions

AlcoholismAttention Deficit Disorders With HyperactivityAttention Deficit Hyperactivity DisorderDrug InteractionsHealthyPharmacokinetics

Phase 1

A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00890292

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorder

Start: 2009-05-31End: 2009-12-31Updated: 2010-04-16

A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00890240

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorder

Start: 2009-05-31End: 2009-11-30Updated: 2010-04-16

A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women

WithdrawnNCT00915668

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Drug Interactions, Healthy, Pharmacokinetics

End: 2011-03-31Updated: 2016-09-20

A Study to Characterize the Pharmacokinetics and Effect of Food on JNJ-31001074 in Healthy Volunteers

CompletedNCT00915434

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Healthy, Pharmacokinetics

Start: 2009-06-30End: 2009-11-30Updated: 2010-04-26

Phase 2

A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.

CompletedNCT00566449

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Attention Deficit Hyperactivity Disorder

Start: 2007-12-31End: 2008-07-31Updated: 2014-05-13

Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults

WithdrawnNCT01362699

Janssen Research & Development, LLCAlcoholism

Start: 2011-08-31End: 2012-08-31Updated: 2012-04-30